Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ming Dong Zhou | M | 69 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
 Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China.
Zensun USA, Inc.
 Zensun USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Zensun (Shanghai) Sci & Tech Co., Ltd., Zensun USA, Inc. is a company that manufactures bio-therapeutic products. The company is based in San Diego, CA. The company was founded by Xi Fu Liu. | 24 years |
| Xin Yan Li | M | - |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China.
Zensun USA, Inc.
Zensun USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Zensun (Shanghai) Sci & Tech Co., Ltd., Zensun USA, Inc. is a company that manufactures bio-therapeutic products. The company is based in San Diego, CA. The company was founded by Xi Fu Liu. | 17 years |
| Xiu Hua Zhang | F | 49 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 22 years |
| Zheng Gang Jiang | M | 45 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 16 years |
| Ting Dai | F | 45 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 19 years |
| Kate Vilaychack-Rizzo | F | - |
Zensun USA, Inc.
Zensun USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Zensun (Shanghai) Sci & Tech Co., Ltd., Zensun USA, Inc. is a company that manufactures bio-therapeutic products. The company is based in San Diego, CA. The company was founded by Xi Fu Liu.
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 10 years |
| Ting Fang Cao | F | 46 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 22 years |
| Wen Hong Jin | M | 74 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 11 years |
| Bin Xi | M | - |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 23 years |
| Tso Hsiu Ho | M | 96 |
Chinese Academy of Sciences
| 31 years |
| Xiao Long Liu | M | 67 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 9 years |
| Bhawanjit K. Brar | M | - |
Zensun USA, Inc.
Zensun USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Zensun (Shanghai) Sci & Tech Co., Ltd., Zensun USA, Inc. is a company that manufactures bio-therapeutic products. The company is based in San Diego, CA. The company was founded by Xi Fu Liu. | - |
| Ming Lin Li | M | - |
Zensun USA, Inc.
Zensun USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Zensun (Shanghai) Sci & Tech Co., Ltd., Zensun USA, Inc. is a company that manufactures bio-therapeutic products. The company is based in San Diego, CA. The company was founded by Xi Fu Liu. | - |
| Yan Jin | F | 46 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 9 years |
| Chen Zhu Ge | M | 45 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 8 years |
| Xiao Yan Qin | M | 40 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 10 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Li Min Xiao | M | 54 |
Chinese Academy of Sciences
| 3 years |
| Ling Wang | M | 67 |
Chinese Academy of Sciences
| 3 years |
| Guan Fu Song | M | 55 |
Chinese Academy of Sciences
| 5 years |
| Ting Xu | M | 51 |
Chinese Academy of Sciences
| 4 years |
| Chun Ling Li | M | 53 |
Chinese Academy of Sciences
| 3 years |
| Erwan Mao | M | 61 |
Chinese Academy of Sciences
| 3 years |
| Xue Jun Song | M | 61 |
Chinese Academy of Sciences
| 3 years |
| Guo Liang Wang | M | 63 |
Chinese Academy of Sciences
| 1 years |
| Hua Jiang | M | - |
Chinese Academy of Sciences
| 3 years |
| Sheng Liu | M | 52 |
Chinese Academy of Sciences
| 1 years |
| Min Ju Zhang | M | 59 |
Chinese Academy of Sciences
| 1 years |
| Qing Li Wang | M | - |
Chinese Academy of Sciences
| 21 years |
| Wen Zhong Shen | M | 56 |
Chinese Academy of Sciences
| 3 years |
| Zhang Lin | M | 52 |
Chinese Academy of Sciences
| 3 years |
| Man Di Sun | M | 52 |
Chinese Academy of Sciences
| 2 years |
| Hu Cai | M | 53 |
Chinese Academy of Sciences
| 5 years |
| Wei Zhao | F | - |
Chinese Academy of Sciences
| 1 years |
| An Rong Dang | M | 60 |
Chinese Academy of Sciences
| 3 years |
| Bao Hong He | M | 52 |
Chinese Academy of Sciences
| 3 years |
| Kai Xu | M | 58 |
Chinese Academy of Sciences
| 1 years |
| Haitao Zhu | M | - |
Chinese Academy of Sciences
| 3 years |
| Zhi Jie Liu | M | 62 |
Chinese Academy of Sciences
| 3 years |
| Yong Quan Liang | M | 56 |
Chinese Academy of Sciences
| 3 years |
| Yusheng Wang | M | 81 |
Chinese Academy of Sciences
| 7 years |
| Xiao Zhong Qu | M | 53 |
Chinese Academy of Sciences
| 3 years |
| Tao Lu | M | 56 |
Chinese Academy of Sciences
| 2 years |
| Guosheng Wu | M | - |
Chinese Academy of Sciences
| 1 years |
| Qiang Liu | M | 55 |
Chinese Academy of Sciences
| 3 years |
| Bin Lü | M | 51 |
Chinese Academy of Sciences
| 1 years |
| Sun Li Ming | F | - |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | - |
| Jun Liang | M | 59 |
Chinese Academy of Sciences
| 6 years |
| Tiancun Xiao | M | - |
Chinese Academy of Sciences
| 3 years |
| De Chao Yu | M | 61 |
Chinese Academy of Sciences
| 3 years |
| Lai Wu Luo | M | 54 |
Chinese Academy of Sciences
| 3 years |
| Bing Feng | M | 56 |
Chinese Academy of Sciences
| 1 years |
| Zi Qiang Hou | M | 85 |
Chinese Academy of Sciences
| 5 years |
| Wentao Hu | M | - |
Chinese Academy of Sciences
| 3 years |
| Qixian Zhang | M | 83 |
Chinese Academy of Sciences
| 30 years |
| Yiping Tan | M | - |
Chinese Academy of Sciences
| 3 years |
| Xu Lingfei | M | - |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | - |
| Wu Xiaofeng | M | - |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | - |
| Wensheng Liao | M | - |
Chinese Academy of Sciences
| 3 years |
| Hong Zhang Wang | M | 62 |
Chinese Academy of Sciences
| 3 years |
| Gao Feng | M | - |
Chinese Academy of Sciences
| 1 years |
| Xiao Di Shen | M | 58 |
Chinese Academy of Sciences
| 3 years |
| Guo Qiang Lin | M | 81 |
Chinese Academy of Sciences
| 6 years |
| Hong Zhang | F | 53 |
Chinese Academy of Sciences
| 1 years |
| Wen Liu | M | - |
Chinese Academy of Sciences
| 3 years |
| Xiaobao Zhang | M | 66 |
Chinese Academy of Sciences
| 4 years |
| Yi Ming Wang | M | 58 |
Chinese Academy of Sciences
| 3 years |
| William Pan | M | - |
Chinese Academy of Sciences
| 3 years |
| John Pan | M | - |
Chinese Academy of Sciences
| 3 years |
| Jian Fang Gui | M | 68 |
Chinese Academy of Sciences
| 3 years |
| Wenqi Gu | M | 82 |
Chinese Academy of Sciences
| 11 years |
| Wu Li | M | 58 |
Chinese Academy of Sciences
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 69 | 97.18% |
| United States | 5 | 7.04% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Xi Fu Liu
- Personal Network
